TEV-53408

DRUG3 trials

Sponsors

Teva Branded Pharmaceutical Products R&D LLC

Conditions

Celiac DiseaseVitiligo

Phase 1

A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo

Active, not recruitingNCT06625177

Teva Branded Pharmaceutical Products R&D LLCVitiligo

Start: 2024-11-11End: 2029-01-31Target: 66Updated: 2026-09-01

Phase 2

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Active, not recruitingNCT06807463

Teva Branded Pharmaceutical Products R&D LLCCeliac Disease

Start: 2025-03-31End: 2027-09-14Updated: 2026-08-26

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults with Celiac Disease While Undergoing Oral Gluten Exposure

Not yet recruitingCTIS2024-517081-42-00

Teva Branded Pharmaceutical Products R&D LLCCeliac Disease

Target: 5Updated: 2025-09-10